OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
AMBS
Amarantus Bioscience Holdings, Inc.
Common Stock
Warning! This security is eligible for Unsolicited Quotes Only
This stock is not eligible for proprietary broker-dealer quotations. All quotes in this stock reflect unsolicited customer orders. Unsolicited-Only stocks have a higher risk of wider spreads, increased volatility, and price dislocations. Investors may have difficulty selling this stock. An initial review by a broker-dealer under SEC Rule15c2-11 is required for brokers to publish competing quotes and provide continuous market making.Warning! This security is traded on the Expert Market
The Expert Market® serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing. OTC Markets Group may designate securities for quoting on the Expert Market when it is not able to confirm that the company is making current information publicly available under SEC Rule 15c2-11, or when the security is otherwise restricted from public quoting. See additional information about the Expert Market here.N/A
N/A
N/A
N/A
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
ETRF | 24.90 | >year | |
CDEL | 21.92 | 03/16 | |
MACM | 18.95 | >year | |
NITE | 18.95 | >year | |
CSTI | 18.55 | >year |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
INTL | 19.40 | >year | |
NITE | 19.40 | >year | |
MACM | 19.43 | >year | |
MAXM | 20.11 | >year | |
CANT | 22.05 | >year |
No Real Time Level 2 Quotes Available on Expert Tier
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 05/06/2025 | 09:30:05 | 0.000001 | -0.00 | 1,500 |
| 05/02/2025 | 09:31:00 | 0.0003 | 0.00 | 846 |
| 05/02/2025 | 09:30:06 | 0.0001 | 0.00 | 7,020 |
| 05/01/2025 | 09:30:05 | 0.000001 | -0.00 | 356 |
| 04/25/2025 | 09:47:37 | 0.0001 | 0.00 | 177,021 |
News
Filings and Disclosure
Company Description
Amarantus Bioscience Holdings (AMBS) is a biotechnology company developing treatments and diagnostics for diseases in the areas of neurology, regenerative medicine and orphan diseases through its subsidiaries. AMBS acquired the rights to the Engineered Skin Substitute program (ESS), a regenerative medicine-based approach for treating severe burns with full-thickness autologous skin grown in tissue culture that is being pursued by AMBS' wholly-owned subsidiary Cutanogen Corporation. AMBS' wholly-owned subsidiary MANF Therapeutics, Inc. owns key intellectual property rights and licenses from a number of prominent universities related to the development of the therapeutic protein known as mesencephalic astrocyte-derived neurotrophic factor ("MANF"). MANF Therapeutics, Inc. is developing MANF-based products as treatments for brain and ophthalmic disorders. MANF was discovered by the Company's Chief Scientific Officer John Commissiong, PhD. Dr. Commissiong discovered MANF from AMBS' proprietary discovery engine PhenoGuard. AMBS sold subsidiary Breakthrough Diagnostics to Todos Medical Ltd. in July of 2020. The Company also owns 51% of hemp/CBD company Hempori.
Videos
This company has not added any videos
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
50.75
Change
-0.05 (-0.10%)
Bid
50.00
Ask
50.80
Volume
710
Time
10:50
